IL128500A - SUBSTITUTED 1,2,3,4-TETRAHYDRO-2-DIBENZOFURANAMINES AND 2-AMINOCYCLOHEPTA[b] BENZOFURANS AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM - Google Patents

SUBSTITUTED 1,2,3,4-TETRAHYDRO-2-DIBENZOFURANAMINES AND 2-AMINOCYCLOHEPTA[b] BENZOFURANS AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM

Info

Publication number
IL128500A
IL128500A IL12850097A IL12850097A IL128500A IL 128500 A IL128500 A IL 128500A IL 12850097 A IL12850097 A IL 12850097A IL 12850097 A IL12850097 A IL 12850097A IL 128500 A IL128500 A IL 128500A
Authority
IL
Israel
Prior art keywords
aminocyclohepta
substituted
dibenzofuranamines
benzofurans
tetrahydro
Prior art date
Application number
IL12850097A
Other languages
English (en)
Other versions
IL128500A0 (en
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of IL128500A0 publication Critical patent/IL128500A0/xx
Publication of IL128500A publication Critical patent/IL128500A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/91—Dibenzofurans; Hydrogenated dibenzofurans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/93—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems condensed with a ring other than six-membered
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Furan Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Polyethers (AREA)
IL12850097A 1996-08-28 1997-08-25 SUBSTITUTED 1,2,3,4-TETRAHYDRO-2-DIBENZOFURANAMINES AND 2-AMINOCYCLOHEPTA[b] BENZOFURANS AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM IL128500A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US2474596P 1996-08-28 1996-08-28
PCT/US1997/014938 WO1998008502A1 (en) 1996-08-28 1997-08-25 SUBSTITUTED 1,2,3,4-TETRAHYDRO-2-DIBENZOFURANAMINES AND 2-AMINOCYCLOHEPTA[b]BENZOFURANS

Publications (2)

Publication Number Publication Date
IL128500A0 IL128500A0 (en) 2000-01-31
IL128500A true IL128500A (en) 2003-06-24

Family

ID=21822177

Family Applications (1)

Application Number Title Priority Date Filing Date
IL12850097A IL128500A (en) 1996-08-28 1997-08-25 SUBSTITUTED 1,2,3,4-TETRAHYDRO-2-DIBENZOFURANAMINES AND 2-AMINOCYCLOHEPTA[b] BENZOFURANS AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM

Country Status (23)

Country Link
EP (1) EP0929299B1 (sh)
JP (1) JP2000516957A (sh)
KR (1) KR20000035942A (sh)
CN (1) CN1228695A (sh)
AT (1) ATE251457T1 (sh)
AU (1) AU741324B2 (sh)
BR (1) BR9711273A (sh)
CA (1) CA2264267A1 (sh)
CZ (1) CZ64499A3 (sh)
DE (1) DE69725459T2 (sh)
DK (1) DK0929299T3 (sh)
EA (1) EA001912B1 (sh)
ES (1) ES2208948T3 (sh)
HU (1) HUP9902901A3 (sh)
IL (1) IL128500A (sh)
NO (1) NO990849L (sh)
NZ (1) NZ334031A (sh)
PL (1) PL331882A1 (sh)
PT (1) PT929299E (sh)
TR (1) TR199900430T2 (sh)
UA (1) UA48245C2 (sh)
WO (1) WO1998008502A1 (sh)
YU (1) YU10499A (sh)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
UA52778C2 (uk) 1997-10-10 2003-01-15 Янссен Фармацевтика Н.В. Галогенозаміщені тетрациклічні похідні тетрагідрофурану, спосіб їх отримання та композиція на їх основі
TWI263497B (en) 2002-03-29 2006-10-11 Lilly Co Eli Pyridinoylpiperidines as 5-HT1F agonists
ES2388547T3 (es) 2003-04-18 2012-10-16 Eli Lilly And Company Compuestos de (piperidiniloxi)fenilo, (piperidiniloxi)piridinilo, (piperidinilsulfanil)fenilo y (piperidinilsulfanil)piridinilo como agonistas de 5-HT 1F
UA82711C2 (en) 2003-09-12 2008-05-12 Эли Лилли Энд Компани Substituted 2-carbonylamino-6-piperidinaminopyridines and substituted 1-carbonylamino-3-piperidinaminobenzenes as 5-ht1f agonists
JP2007516266A (ja) 2003-12-17 2007-06-21 イーライ リリー アンド カンパニー ５−ｈｔ１ｆアゴニストとしての置換（４−アミノシクロヘキセン−１−イル）フェニルおよび（４−アミノシクロヘキセン−１−イル）ピリジニル化合物
CN1318411C (zh) * 2005-03-21 2007-05-30 中国海洋大学 氢化轮枝霉酮类化合物及其制备方法和用途
US8697876B2 (en) 2010-04-02 2014-04-15 Colucid Pharmaceuticals, Inc. Compositions and methods of synthesis of pyridinolypiperidine 5-HT1F agonists
CN102887880B (zh) * 2012-08-20 2014-10-29 东南大学 二苯并呋喃衍生物及其制备方法与用途
TWI829107B (zh) 2019-07-09 2024-01-11 美商美國禮來大藥廠 大規模製備2,4,6-三氟-n-[6-(1-甲基-哌啶-4-羰基)-吡啶-2-基]-苯甲醯胺半琥珀酸鹽的方法及中間體，以及2,4,6-三氟-n-[6-(1-甲基-哌啶-4-羰基)-吡啶-2-基]-苯甲醯胺醋酸鹽之製備

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4668690A (en) * 1985-12-30 1987-05-26 Hoechst Roussel Pharmaceuticals Inc. 1,2,3,4,4a,9b-hexahydro-4a-aminoalkyldibenzofurans useful as analgesics, anticonvulsants or antidepressants
US5698571A (en) * 1994-10-05 1997-12-16 Eli Lilly And Company 5-HT1F mediated inhibition of neurogenic meningeal extravasation: a method for the treatment of migraine
US5521196A (en) * 1994-10-05 1996-05-28 Eli Lilly And Company 5-HT1F agonists for the treatment of migraine

Also Published As

Publication number Publication date
JP2000516957A (ja) 2000-12-19
AU741324B2 (en) 2001-11-29
CZ64499A3 (cs) 1999-05-12
PL331882A1 (en) 1999-08-16
EP0929299B1 (en) 2003-10-08
IL128500A0 (en) 2000-01-31
CN1228695A (zh) 1999-09-15
EP0929299A4 (en) 2000-12-20
PT929299E (pt) 2004-02-27
HUP9902901A2 (hu) 2000-05-28
NO990849D0 (no) 1999-02-23
NO990849L (no) 1999-02-23
ES2208948T3 (es) 2004-06-16
NZ334031A (en) 2000-07-28
EA199900241A1 (ru) 1999-08-26
DK0929299T3 (da) 2004-02-16
BR9711273A (pt) 1999-08-17
CA2264267A1 (en) 1998-03-05
DE69725459D1 (de) 2003-11-13
TR199900430T2 (xx) 1999-06-21
AU4088097A (en) 1998-03-19
WO1998008502A1 (en) 1998-03-05
EP0929299A1 (en) 1999-07-21
ATE251457T1 (de) 2003-10-15
YU10499A (sh) 2001-03-07
DE69725459T2 (de) 2004-08-12
HUP9902901A3 (en) 2002-01-28
KR20000035942A (ko) 2000-06-26
UA48245C2 (uk) 2002-08-15
EA001912B1 (ru) 2001-10-22

Similar Documents

Publication Publication Date Title
YU15299A (sh) Farmaceutski sastavi
EP0960107A4 (sh)
ZA97222B (en) Lubricating compositions.
ZA97223B (en) Lubricating compositions.
BG103384A (en) Halogenpyrimidinylaryl (thio)ethers as pesticides
HU0500549D0 (en) Azolo-pyridimidines, pharmaceutical compositions containing the same and use thereof
HUP9902455A3 (en) 6-phenylpyridyl-2-amine derivatives, pharmaceutical compositions containing them
ZA9711313B (en) Stilbene compounds containing an adamantyl-group, compositions containing them and uses thereof.
ZA978178B (en) Composition.
ZA9710071B (en) Pharmaceutical composition.
ZA9710593B (en) Antisebum and antioxidant compositions containing gugulipid and fractions thereof.
ZA974735B (en) Pharmaceutical compositions.
ZA964473B (en) Endoparasiticidal compositions.
ZA975261B (en) Composition.
HK1019757A1 (en) Synthetic polysaccharides, preparation method therefor and pharmaceutical compositions containing same.
BG104916A (en) Calcilytic compounds
IL136942A0 (en) Polyethoxylated castor oil, compositions containing the same and processes for the preparation thereof
AU5892399A (en) 1, 2, 4-triazole-3-thione compounds
ZA97944B (en) N: 1 Transcoder.
IL128500A (en) SUBSTITUTED 1,2,3,4-TETRAHYDRO-2-DIBENZOFURANAMINES AND 2-AMINOCYCLOHEPTA[b] BENZOFURANS AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
HUP0002861A3 (en) Benzothiophene derivatives, and compositions containing the same
ZA971746B (en) Taxoids, their preparation and pharmaceutical compositions containing them.
IL121969A0 (en) 10,13,15-trioxatricyclo[9.2.1.1.9.6]-pentadecanone derivatives their preparation and pharmaceutical compositions containing them
MY127474A (en) Naphthyl compounds, intermediates, compositions, and methods of use
BG102229A (en) Endothelium receptor antagonists

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed
MM9K Patent not in force due to non-payment of renewal fees